Associated Papers
Precision screening facilitates clinical classification of BRCA2-PALB2 binding variants with benign and pathogenic functional effects.
Bose M et al.
The Journal of Clinical Investigation, 2025
40232841 (PubMed )
Supplement: jci-135-181879-s033.xlsx › Supplementary_Table_4
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.
Yamaguchi TN et al.
Cancer Discovery, 2025
39945744 (PubMed )
Supplement: cd-23-0882_supplementary_table_1_suppst1.xlsx › Replication_cohort
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.
Diossy M et al.
Npj Precision Oncology, 2024
39294262 (PubMed )
Supplement: 41698_2024_705_MOESM3_ESM.xlsx › Supplementary_Data2
Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2.
Aljarf R et al.
Scientific Reports, 2022
35729312 (PubMed )
Supplement: 41598_2022_13508_MOESM2_ESM.xlsx › Sheet1
Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma.
Wong K et al.
Nature Communications, 2019
30664638 (PubMed )
Supplement: 41467_2018_8081_MOESM5_ESM.xlsx › Equine-all_other
Select a paper to view details